Modification and Psychometric Testing of the German-Language Revised Illness Perception Questionnaire (IPQ-R) in Occupational Dermatological Rehabilitation
Abstract
1. Introduction
1.1. Common Sense Model of Self-Regulation
- Identity (e.g., symptoms causally associated and perceived with the disease, name of the disease);
- Cause (e.g., suspected causal links via the triggers of the patient’s own illness);
- Timeline (e.g., expectations about the duration and (acute/chronic or cyclical) course of the disease);
- Controllability (e.g., assumptions about the ability to influence the disease through one’s own behaviour or therapeutic interventions);
- Consequences (e.g., assumptions about the short and long term, psychological, social, emotional, physical and/or economic consequences of the disease);
- Illness coherence (e.g., extent to which the disease is comprehensible).
1.2. Instrument: Illness Perception Questionnaire—Revised Version
1.3. Application Area: Occupational Dermatology
1.4. Objective
- (1)
- to develop a German-language version of the IPQ-R adapted for occupational dermatology based on the existing instrument [9] and;
- (2)
- to use this modified instrument in occupational dermatological rehabilitation for the first time and to test it psychometrically.
2. Material and Methods
2.1. Modifications and Item Development
2.2. Data Collection and Sample
2.3. Statistical Data Analysis
3. Results
3.1. Sample Description and Acceptance of the Items
3.2. Factorial Structure of the Disease Assumptions
- Examination of the requirements and initial analysis
- Item allocation
- Final analysis results
- Result after scale analysis
- Intercorrelations
3.3. Factorial Structure of the Causes of Disease
- Examination of the requirements and initial analysis
- Item allocation and item exclusion
- Further analysis
- Final analysis results
- Item and scale analysis of the causes of illness
- Intercorrelations
4. Discussion
4.1. Illness Perceptions
4.2. Treatment Control
4.3. Timeline (Acute/Chronic)
4.4. Consequences
4.5. Timeline (Cyclical)
4.6. Causes
- (I)
- Behavioural risk factors, such as substance use (C14 and C15), diet, and eating habits (C4), are distributed across two factors (factors 4 and 6).
- (II)
- C5 “chance or bad luck” and C16 “accident or injury”, which form the construct “chance” in the original model, are distributed over two risk-associated factors in this model. The instability of the original factor is also evident in other studies [13,15]: Wittkowski et al. [13] were also unable to replicate the factors “chance” and “immunity” in their EFA.
4.7. Strengths and Limitations
4.8. Core Messages
- On the basis of the existing German-language instrument;
- With an analysis of survey instruments for assessing skin condition;
- Using content-related considerations on expected consequences resulting from a patient survey in health psychology patient seminars during occupational dermatological rehabilitation;
- Based on the results of Rocholl et al. [6].
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Leventhal, H.; Phillips, L.A.; Burns, E. The Common-Sense Model of Self-Regulation (CSM): A dynamic framework for understanding illness self-management. J. Behav. Med. 2016, 39, 935–946. [Google Scholar] [CrossRef]
- Petrie, K.J.; Weinman, J. Why illness perceptions matter. Clin. Med. 2006, 6, 536–539. [Google Scholar] [CrossRef]
- Benyamini, Y.; Karademas, E.C. Introduction to the special issue on the common sense model of self-regulation. Health Psychol. Rev. 2019, 13, 373–377. [Google Scholar] [CrossRef] [PubMed]
- Diefenbach, M.A.; Leventhal, H. The Common-Sense Model of Illness Representation: Theoretical and Practical Considerations. J. Soc. Distress Homeless 1996, 5, 11–38. [Google Scholar] [CrossRef]
- Hagger, M.S.; Orbell, S. A Meta-Analytic Review of the Common-Sense Model of Illness Representations. Psychol. Health 2003, 18, 141–184. [Google Scholar] [CrossRef]
- Rocholl, M.; Ludewig, M.; Brakemeier, C.; John, S.M.; Wilke, A. Illness perceptions of adults with eczematous skin diseases: A systematic mixed studies review. Syst. Rev. 2021, 10, 141. [Google Scholar] [CrossRef] [PubMed]
- Wittkowski, A.; Richards, H.L.; Griffiths, C.E.M.; Main, C.J. Illness perception in individuals with atopic dermatitis. Psychol. Health Med. 2007, 12, 433–444. [Google Scholar] [CrossRef]
- Solmaz, N.; Ilhan, N.; Bulut, H.M. The effect of illness perception on life quality in psoriasis patients. Psychol. Health Med. 2021, 26, 955–967. [Google Scholar] [CrossRef]
- Moss-Morris, R.; Weinman, J.; Petrie, K.; Horne, R.; Cameron, L.; Buick, D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol. Health 2002, 17, 1–16. [Google Scholar] [CrossRef]
- Scharloo, M.; Kaptein, A.A.; Weinman, J.; Bergman, W.; Vermeer, B.; Rooijmans, H. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: A 1-year follow-up. Br. J. Dermatol. 2000, 142, 899–907. [Google Scholar] [CrossRef] [PubMed]
- Fortune, D.G.; Richards, H.L.; Main, C.J.; Griffiths, C.E. What patients with psoriasis believe about their condition. J. Am. Acad. Dermatol. 1998, 39, 196–201. [Google Scholar] [CrossRef]
- Nordbø, E.C.A.; Aamodt, G.; Ihlebæk, C.M. Subjective Health Complaints in Individuals with Psoriasis and Psoriatic Arthritis: Associations with the Severity of the Skin Condition and Illness Perceptions—A Cross-Sectional Study. Int. J. Behav. Med. 2017, 24, 438–446. [Google Scholar] [CrossRef]
- Wittkowski, A.; Richards, H.L.; Williams, J.; Main, C.J. Factor analysis of the Revised Illness Perception Questionnaire in adults with atopic dermatitis. Psychol. Health Med. 2008, 13, 346–359. [Google Scholar] [CrossRef]
- Broadbent, E.; Petrie, K.J.; Main, J.; Weinman, J. The brief illness perception questionnaire. J. Psychosom. Res. 2006, 60, 631–637. [Google Scholar] [CrossRef]
- Surgenor, L.J.; Snell, D.L.; Siegert, R.J.; Kelly, S.; Flint, R.; Coulter, G. Psychometric Characteristics of the Revised Illness Perception Questionnaire (IPQ-R) in People Undergoing Weight Loss Surgery. J. Clin. Psychol. Med. Settings 2020, 27, 79–88. [Google Scholar] [CrossRef]
- Gaab, J.; Latanzia-Bunschoten, S.; Sprott, H. llness Perception Questionnaire. In Diagnostische Verfahren in der Rehabilitation. Bd. 5. Diagnostik für Klinik und Praxis; Bengel, J., Wirtz, M., Zwingmann, C., Eds.; Hogrefe: Göttingen, Germany, 2008; pp. 109–111. [Google Scholar]
- Glattacker, M.; Bengel, J.; Jäckel, W.H. Die deutschsprachige Version des Illness Perception Questionnaire-Revised. Z. Gesundheitspsychol. 2009, 17, 158–169. [Google Scholar] [CrossRef]
- Hagger, M.S.; Orbell, S. A confirmatory factor analysis of the revised illness perception questionnaire (IPQ-R) in a cervical screening context. Psychol. Health 2005, 20, 161–173. [Google Scholar] [CrossRef]
- Brans, R.; John, S.M. Clinical patterns and associated factors in patients with hand eczema of primarily occupational origin. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 798–805. [Google Scholar] [CrossRef] [PubMed]
- Elsner, P. The, “dermatologist’s procedure” after the abolition of the obligation to refrain from risky work activities in occupational disease law: [Das Hautarztverfahren nach Aufhebung des Unterlassungszwangs im Berufskrankheitenrecht]. Hautarzt 2021, 72, 509–515. [Google Scholar] [CrossRef]
- Skudlik, C.; Weisshaar, E. Individuelle ambulante und stationäre Prävention bei Berufsdermatosen. Hautarzt 2015, 66, 160–166. [Google Scholar] [CrossRef] [PubMed]
- Brans, R.; Skudlik, C.; Weisshaar, E.; Scheidt, R.; Ofenloch, R.; Elsner, P.; Wulfhorst, B.; Schönfeld, M.; John, S.M.; Diepgen, T.L.; et al. Multicentre cohort study ‘Rehabilitation of Occupational Skin Diseases-Optimization and Quality Assurance of Inpatient Management (ROQ)’: Results from a 3-year follow-up. Contact Dermat. 2016, 75, 205–212. [Google Scholar] [CrossRef]
- Susitaival, P.; Flyvholm, M.-A.; Meding, B.; Kanerva, L.; Lindberg, M.; Svensson, Å.; Ólafsson, J.H. Nordic Occupational Skin Questionnaire (NOSQ-2002): A new tool for surveying occupational skin diseases and exposure. Contact Dermat. 2003, 49, 70–76. [Google Scholar] [CrossRef]
- Dulon, M.; Nübling, M.; Skudlik, C.; Nienhaus, A. Validierung des Osnabrück Handekzem-Schwere-Index. Zbl Arbeitsmed 2010, 60, 304–305. [Google Scholar] [CrossRef]
- Schobbe, M.; Böhm, C.; John, S.M.; Wilke, A.; Meyer, J. Subjektive Krankheitsannahmen von Patienten mit berufsbedingtem Handekzem-eine Pilotstudie zur Erprobung des IPQ-R in der stationären Tertiären Individual-Prävention. Dermatol. Beruf Umw. 2019, 67, 118–119. [Google Scholar]
- Pohontsch, N.; Meyer, T. Das kognitive Interview—Ein Instrument zur Entwicklung und Validierung von Erhebungsinstrumenten. Rehabilitation 2015, 54, 53–59. [Google Scholar] [CrossRef]
- IBM Corp. IBM SPSS Statistics for Windows, version 26.0; IBM Corp: Armonk, NY, USA, 2019.
- Glattacker, M.; Heyduck, K.; Meffert, C. Entwicklung eines Fragebogens zur Erfassung des subjektiven Behandlungskonzepts von Rehabilitanden. Rehabilitation 2009, 48, 345–353. [Google Scholar] [CrossRef] [PubMed]
- Wirtz, M. Über das Problem fehlender Werte: Wie der Einfluss fehlender Informationen auf Analyseergebnisse entdeckt und reduziert werden kann. Rehabilitation 2004, 43, 109–115. [Google Scholar] [CrossRef] [PubMed]
- Kline, R.B. Principles and practice of structural equation modeling. In Methodology in the Social Sciences; Guilford Press: New York, NY, USA, 2016. [Google Scholar]
- Eid, M.; Schmidt, K. Testtheorie und Testkonstruktion. In Bachelorstudium Psychologie; Hogrefe: Göttingen, Germany, 2014. [Google Scholar]
- Braeken, J.; van Assen, M.A.L.M. An empirical Kaiser criterion. Psychol. Methods 2017, 22, 450–466. [Google Scholar] [CrossRef]
- Osborne, J.W.; Costello, A.B. Sample size and subject to item ratio in principal components analysis. Pract. Assess. Res. Eval. 2004, 9, 11. [Google Scholar]
| IP1 * | My hand eczema will last a short time |
| IP2 | My hand eczema will last a long time |
| IP3 * | My hand eczema will pass quickly |
| IP4 | I expect to have my hand eczema for the rest of my life |
| IP5 | My hand eczema has major consequences on my life |
| IP6 * | My hand eczema does not have much effect on my life |
| IP7 | My hand eczema strongly affects the way others see me |
| IP8 | My hand eczema has serious financial consequences |
| IP9 | My hand eczema causes difficulties for those who are close to me |
| IP10 | There is a lot which I can do to control my symptoms |
| IP11 | What I do can determine whether my hand eczema gets better or worse |
| IP12 | The course of my hand eczema depends on me |
| IP13 | I have the power to influence my hand eczema |
| IP14 * | My hand eczema will improve in time |
| IP15 * | There is very little that can be done to improve my hand eczema |
| IP16 | My treatment will be effective in curing my hand eczema |
| IP17 | The negative effects of my hand eczema can be prevented (avoided) by my treatment |
| IP18 | My treatment can control my hand eczema |
| IP19 * | The symptoms of my hand eczema are puzzling to me |
| IP20 * | My hand eczema is a mystery to me |
| IP21 * | I don’t understand my hand eczema |
| IP22 * | My hand eczema doesn’t make any sense to me |
| IP23 | I have a clear picture or understanding of my condition |
| IP24 | The symptoms of my hand eczema a great deal from day to day |
| IP25 | My symptoms come and go in cycles |
| IP26 | My hand eczema is very unpredictable |
| IP27 | I go through cycles in which my hand eczema gets better and worse |
| IP28 | I get depressed when I think about my hand eczema |
| IP29 | When I think about my hand eczema I get upset |
| IP30 | My hand eczema makes me feel angry |
| IP31 | Having this hand eczema makes me feel anxious |
| IP32 | My hand eczema makes me feel afraid |
| N1 | My hand eczema has an impact on my professional activity |
| N2 | My hand eczema has an impact on activities of daily life (e.g., cleaning, washing dishes, etc.) |
| N3 | My hand eczema has an impact on my leisure activities (e.g., hobbies, social activities, etc.) |
| N4 | My hand eczema has an impact on my partnership |
| NC1 | Hormone fluctuations |
| NC2 | Activities at work |
| NC3 | Activities outside of work |
| NC4 | Skin-irritating substances at work |
| NC5 | Skin-irritating substances outside of work |
| NC6 | Sensitising substances at work |
| NC7 | Sensitising substances outside of work |
| NC8 | Hand washing |
| NC9 | Hand disinfection |
| NC10 | Creams |
| NC11 | Wearing gloves |
| NC12 | Inadequate/lack of skin protection at work |
| NC13 | Climatic influences at work (e.g., cold, heat, dust exposure, solar radiation) |
| NC14 | Climatic influences outside of work (e.g., cold, heat, dust exposure, solar radiation) |
| NC15 | Working atmosphere (e.g., cooperation with colleagues/employer) |
| Frequency | Percent | |
|---|---|---|
| Sex | ||
| Female | 123 | 53.9% |
| Male | 105 | 46.1% |
| Diverse | 0 | 0.0% |
| Age group | ||
| 18–20 years | 1 | 0.4% |
| 20–29 years | 29 | 12.7% |
| 30–39 years | 24 | 10.5% |
| 40–49 years | 33 | 14.5% |
| 50–59 years | 108 | 47.4% |
| 60–69 years | 33 | 14.5% |
| Living in a partnership | ||
| Yes | 171 | 75.0% |
| No | 55 | 24.1% |
| Not specified | 2 | 0.9% |
| Educational qualification | ||
| No school-leaving qualification | 1 | 0.4% |
| Secondary school-leaving certificate | 64 | 28.1% |
| Secondary school-leaving certificate | 100 | 43.9% |
| Advanced technical college entrance qualification | 30 | 13.2% |
| General higher education entrance qualification/abitur | 19 | 8.3% |
| Bachelor’s degree | 3 | 1.3% |
| Master/diploma | 4 | 1.8% |
| Promotion | 2 | 0.9% |
| Not specified | 5 | 2.2% |
| Duration of the skin disease | ||
| ≤1 year | 25 | 11.0% |
| 1 ≤ 2 years | 54 | 23.7% |
| 2 ≤ 5 years | 56 | 24.6% |
| 5 ≤ 10 years | 35 | 15.4% |
| 10 ≤ 15 years | 17 | 7.5% |
| 15 ≤ 20 years | 15 | 6.5% |
| 20 ≤ 30 years | 7 | 3.1% |
| ≥30 years | 8 | 3.5% |
| Not specified | 11 | 4.8% |
| Severity of hand eczema at the time of the survey (patient self-assessment) | ||
| Clear | 3 | 1.3% |
| Almost clear | 11 | 4.8% |
| Mild | 26 | 11.4% |
| Moderate | 131 | 57.5% |
| Severe | 45 | 19.7% |
| Not specified/prefer not to say | 12 | 5.2% |
| Factor (Variance Explanation) | Item Characteristics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Items | Factor 1 (18.65%) | Factor 2 (12.01%) | Factor 3 (8.27%) | Factor 4 (6.82%) | Factor 5 (5.51%) | Factor 6 (5.33%) | Factor 7 (3.99%) | Factor 8 (3.37) | Communality | Arithmetic Mean | Corrected Item Discriminatory Power |
| 1 Illness coherence (α = 0.84) | |||||||||||
| IP21 * I don’t understand my hand eczema | 0.878 | −0.131 | −0.073 | −0.046 | 0.026 | 0.089 | 0.076 | −0.063 | 0.81 | 2.88 (1.16) | 0.81 |
| IP20 * My hand eczema is a mystery to me. | 0.873 | −0.122 | −0.042 | −0.041 | −0.061 | 0.105 | 0.037 | −0.047 | 0.80 | 2.88 (1.26) | 0.79 |
| IP19 * The symptoms of my hand eczema are puzzling to me | 0.778 | −0.015 | 0.111 | −0.209 | −0.035 | 0.149 | −0.005 | −0.003 | 0.69 | 2.79 (1.25) | 0.67 |
| IP22 * My hand eczema doesn’t make any sense to me | 0.733 | −0.067 | 0.001 | −0.016 | 0.129 | 0.060 | −0.021 | −0.178 | 0.59 | 3.02 (1.14) | 0.60 |
| IP23 I have a clear picture or understanding of my condition | 0.533 | −0.174 | 0.140 | 0.035 | 0.108 | 0.019 | 0.025 | 0.393 | 0.50 | 3.18 (1.07) | 0.40 |
| 2 Emotional representations (α = 0.82) | |||||||||||
| IP28 I get depressed when I think about my hand eczema | −0.116 | 0.777 | 0.150 | 0.173 | −0.090 | 0.005 | 0.000 | 0.009 | 0.68 | 3.59 (1.11) | 0.67 |
| IP30 My hand eczema makes me feel angry | −0.117 | 0.756 | 0.238 | 0.086 | −0.018 | −0.014 | 0.029 | 0.069 | 0.66 | 3.29 (1.17) | 0.63 |
| IP31 Having this hand eczema makes me feel anxious | −0.162 | 0.724 | −0.082 | 0.298 | −0.106 | −0.050 | −0.026 | 0.271 | 0.73 | 3.21 (1.12) | 0.69 |
| IP32 When I think about my hand eczema I get upset | −0.185 | 0.710 | −0.022 | 0.319 | −0.023 | −0.053 | −0.057 | 0.292 | 0.73 | 3.11 (1.17) | 0.70 |
| IP29 It worries me when I think about my hand eczema | 0.007 | 0.619 | 0.208 | 0.021 | 0.114 | −0.100 | 0.140 | −0.136 | 0.49 | 3.22 (1.28) | 0.43 |
| 3 Consequences: implications for the structuring of own life (α = 0.78) | |||||||||||
| N2 My hand eczema affects the activities of daily living (e.g., cleaning, washing up, etc.) | 0.067 | 0.184 | 0.840 | 0.100 | 0.071 | 0.008 | 0.111 | 0.037 | 0.77 | 4.33 (0.79) | 0.74 |
| N1 My hand eczema has an impact on my professional activity | 0.188 | 0.042 | 0.745 | 0.097 | 0.104 | −0.105 | 0.059 | 0.152 | 0.65 | 4.34 (0.75) | 0.55 |
| IP5 My hand eczema has major consequences on my life | −0.025 | 0.265 | 0.695 | 0.231 | −0.057 | 0.006 | 0.137 | 0.045 | 0.63 | 4.09 (0.94) | 0.65 |
| N3 My hand eczema has an impact on my leisure activities (e.g., hobbies, social activities, etc.) | −0.112 | 0.039 | 0.693 | 0.382 | −0.008 | 0.052 | 0.027 | 0.023 | 0.64 | 3.95 (1.02) | 0.57 |
| IP6 * My hand eczema does not have much effect on my life | −0.089 | 0.049 | 0.466 | 0.118 | −0.079 | 0.130 | 0.174 | −0.205 | 0.34 | 4.05 (1.11) | 0.38 |
| 4 Consequences: financial and social impacts (α = 0.72) | |||||||||||
| IP9 My hand eczema causes difficulties for those who are close to me | −0.063 | 0.228 | 0.198 | 0.710 | −0.098 | −0.059 | 0.028 | 0.091 | 0.62 | 3.17 (1.21) | 0.58 |
| IP7 My hand eczema strongly affects the way others see me | −0.109 | 0.223 | 0.100 | 0.706 | −0.004 | 0.065 | −0.029 | 0.008 | 0.58 | 2.91 (1.18) | 0.55 |
| IP8 My hand eczema has serious financial consequences | 0.090 | 0.109 | 0.243 | 0.684 | 0.034 | 0.060 | −0.096 | −0.084 | 0.57 | 2.77 (1.18) | 0.46 |
| N4 My hand eczema has an impact on my partnership | −0.157 | 0.074 | 0.182 | 0.615 | −0.138 | −0.053 | 0.076 | 0.147 | 0.49 | 2.84 (1.26) | 0.45 |
| 5 Treatment control (α = 0.81) | |||||||||||
| IP18 My treatment can control my hand eczema | 0.058 | −0.005 | 0.010 | −0.087 | 0.845 | 0.211 | 0.087 | 0.017 | 0.78 | 3.55 (0.86) | 0.70 |
| IP17 The negative effects of my hand eczema can be prevented (avoided) by my treatment | 0.140 | 0.025 | −0.097 | −0.041 | 0.840 | 0.198 | 0.026 | −0.108 | 0.79 | 3.43 (0.92) | 0.70 |
| IP16 My treatment will be effective in curing my hand eczema | −0.086 | −0.064 | 0.151 | −0.057 | 0.784 | −0.024 | −0.151 | 0.022 | 0.68 | 3.54 (0.86) | 0.57 |
| 6 Personal control (α = 0.75) | |||||||||||
| IP11 What I do can determine whether my hand eczema gets better or worse | 0.129 | −0.033 | 0.120 | −0.055 | 0.043 | 0.810 | 0.098 | 0.024 | 0.70 | 3.25 (1.09) | 0.60 |
| IP12 The course of my hand eczema depends on me | 0.078 | 0.096 | 0.120 | −0.024 | 0.026 | 0.796 | −0.171 | 0.009 | 0.70 | 2.80 (1.05) | 0.55 |
| IP13 I have the power to influence my hand eczema | 0.185 | −0.126 | −0.115 | 0.120 | 0.207 | 0.707 | −0.004 | −0.028 | 0.62 | 2.82 (1.10) | 0.59 |
| IP10 There is a lot which I can do to control my symptoms | 0.011 | −0.233 | −0.174 | 0.003 | 0.356 | 0.554 | 0.054 | 0.174 | 0.55 | 3.17 (1.04) | 0.44 |
| 7 Timeline acute/chronic (α = 0.66) | |||||||||||
| IP3 * My hand eczema will pass quickly | 0.104 | −0.055 | 0.013 | 0.072 | 0.014 | −0.001 | 0.784 | 0.105 | 0.65 | 4.04 (0.85) | 0.47 |
| IP1 * My hand eczema will last a short time | −0.057 | −0.004 | 0.218 | −0.099 | −0.077 | 0.117 | 0.755 | −0.160 | 0.68 | 4.23 (0.81) | 0.49 |
| IP2 My hand eczema will last a long time | 0.026 | 0.137 | 0.160 | −0.018 | 0.022 | −0.142 | 0.683 | 0.118 | 0.55 | 4.00 (0.85) | 0.45 |
| −0.080 | 0.182 | −0.001 | 0.114 | −0.066 | 0.110 | 0.010 | 0.744 | 0.62 | 3.28 (1.00) | 0.29 | |
| −0.373 | 0.210 | 0.126 | −0.011 | 0.008 | −0.028 | 0.316 | 0.499 | 0.55 | 3.61 (0.98) | 0.29 | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|
| 1. Illness coherence | 1 | −0.278 ** | −0.009 | −0.166 * | 0.112 | 0.251 ** | 0.052 |
| 2. Emotional representations | 1 | 0.328 ** | 0.454 ** | −0.085 | −0.153 * | 0.073 | |
| 3. Consequences: implications for the structuring of own life | 1 | 0.465 ** | 0.001 | 0.000 | 0.271 ** | ||
| 4. Consequences: financial and social impacts | 1 | −0.132 * | −0.033 | 0.023 | |||
| 5. Treatment control | 1 | 0.332 ** | −0.022 | ||||
| 6. Personal control | 1 | −0.019 | |||||
| 7. Timeline acute/chronic | 1 |
| Factor (Variance Explanation) | Item Characteristics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Items | Factor 1 (21.73%) | Factor 2 (8.82%) | Factor 3 (6.72%) | Factor 4 (6.24%) | Factor 5 (5.76%) | Factor 6 (4.91%) | Factor 7 (4.15%) | Factor 8 (3.88%) | Communality | Arithmetic Mean | Corrected Item Discriminatory Power |
| 1 Psychological causes at work and during leisure time (α = 0.83) | |||||||||||
| C12 My emotional state, e.g., feeling down, lonely, anxious, empty | 0.718 | 0.062 | 0.123 | 0.217 | 0.036 | 0.189 | 0.068 | 0.099 | 0.63 | 2.50 (1.13) | 0.67 |
| C9 My attitude, e.g., thinking about life negatively | 0.711 | 0.092 | 0.104 | 0.296 | 0.076 | 0.009 | 0.002 | −0.049 | 0.62 | 2.16 (0.94) | 0.63 |
| C10 Family problems or worries caused my illness | 0.710 | 0.127 | 0.170 | 0.130 | −0.129 | 0.130 | −0.013 | 0.078 | 0.61 | 2.25 (1.02) | 0.63 |
| C1 Stress and worry | 0.710 | 0.107 | 0.093 | −0.228 | −0.059 | 0.180 | 0.089 | 0.120 | 0.63 | 3.54 (1.12) | 0.55 |
| NC15 Working atmosphere (e.g., cooperation with colleagues/employer) | 0.591 | −0.010 | −0.068 | 0.141 | 0.189 | −0.009 | 0.153 | 0.325 | 0.54 | 2.56 (1.17) | 0.53 |
| C17 My personality | 0.565 | 0.128 | 0.091 | 0.327 | 0.058 | −0.161 | 0.156 | −0.051 | 0.51 | 2.03 (0.95) | 0.49 |
| C11 Overwork | 0.558 | 0.067 | 0.158 | −0.001 | 0.034 | −0.046 | 0.315 | 0.090 | 0.45 | 2.88 (1.13) | 0.52 |
| 2 Attributions outside the workplace (α = 0.79) | |||||||||||
| NC5 Skin-irritating substances outside of work | 0.061 | 0.876 | 0.085 | −0.008 | 0.055 | −0.060 | 0.078 | 0.147 | 0.81 | 3.04 (1.13) | 0.73 |
| NC7 Sensitising substances outside of work | 0.123 | 0.863 | 0.081 | 0.125 | 0.081 | 0.083 | 0.098 | 0.063 | 0.81 | 2.95 (1.10) | 0.73 |
| NC3 Activities outside work | 0.198 | 0.677 | 0.226 | −0.004 | 0.045 | −0.020 | −0.023 | 0.137 | 0.57 | 2.99 (1.08) | 0.57 |
| NC10 Creams | 0.117 | 0.429 | 0.416 | 0.149 | −0.015 | 0.176 | 0.175 | −0.083 | 0.46 | 2.77 (1.12) | 0.38 |
| 3 Skin cleansing and skin protection measures (α = 0.71) | |||||||||||
| NC8 Hand washing | 0.117 | 0.192 | 0.786 | 0.045 | 0.025 | 0.011 | 0.135 | 0.121 | 0.70 | 3.49 (1.08) | 0.58 |
| NC9 Hand disinfection | 0.146 | 0.106 | 0.754 | −0.204 | 0.114 | 0.008 | 0.235 | 0.083 | 0.72 | 3.73 (1.10) | 0.59 |
| NC11 Wearing gloves | 0.188 | 0.089 | 0.652 | 0.042 | 0.218 | 0.104 | −0.108 | −0.044 | 0.54 | 3.47 (1.12) | 0.42 |
| 4 Behaviour-related risk factors (α = 0.64) | |||||||||||
| C16 Accident or injury | 0.059 | 0.149 | −0.060 | 0.726 | 0.135 | 0.107 | 0.035 | −0.105 | 0.78 | 4.17 (0.78) | 0.65 |
| C14 Alcohol | 0.261 | 0.007 | 0.014 | 0.717 | 0.005 | 0.011 | 0.181 | 0.162 | 0.66 | 3.77 (1.01) | 0.50 |
| C15 Smoking | 0.212 | −0.025 | −0.013 | 0.630 | −0.116 | 0.129 | −0.010 | 0.226 | 0.65 | 4.19 (0.76) | 0.49 |
| 5 Causes at work (α = 0.71) | |||||||||||
| NC4 Skin-irritating substances at work | 0.031 | 0.065 | 0.068 | 0.056 | 0.855 | −0.141 | 0.072 | 0.082 | 0.61 | 2.58 (1.04) | 0.47 |
| NC6 Sensitising substances at work | 0.021 | 0.242 | 0.022 | 0.097 | 0.748 | 0.180 | −0.004 | −0.017 | 0.54 | 2.59 (1.10) | 0.37 |
| NC2 Activities at work | 0.021 | −0.130 | 0.225 | −0.106 | 0.744 | −0.042 | −0.052 | 0.125 | 0.61 | 2.70 (0.94) | 0.43 |
| 6 Other risk factors (α = 0.63) | |||||||||||
| C3 A germ or virus | 0.191 | 0.033 | −0.076 | −0.073 | 0.032 | 0.742 | 0.069 | 0.072 | 0.61 | 2.58 (1.04) | 0.47 |
| C5 Chance or bad luck | −0.014 | −0.107 | 0.134 | 0.167 | −0.069 | 0.681 | −0.009 | −0.108 | 0.54 | 2.59 (1.10) | 0.37 |
| C4 Diet or eating habits | 0.458 | 0.205 | 0.021 | 0.004 | 0.055 | 0.512 | 0.285 | −0.110 | 0.61 | 2.70 (0.94) | 0.43 |
| C6 Poor medical care in my past | 0.005 | 0.034 | 0.136 | 0.287 | 0.003 | 0.508 | 0.188 | 0.146 | 0.42 | 2.42 (1.00) | 0.36 |
| 7 External factors that cannot be influenced by the person (α = 0.66) | |||||||||||
| C18 Altered immunity | 0.129 | 0.164 | 0.150 | 0.092 | 0.010 | 0.086 | 0.741 | −0.096 | 0.64 | 2.92 (1.11) | 0.50 |
| C13 Ageing | 0.243 | −0.275 | 0.066 | 0.192 | 0.019 | 0.055 | 0.639 | 0.378 | 0.73 | 2.51 (1.02) | 0.46 |
| NC1 Hormone fluctuations | 0.362 | 0.130 | 0.077 | 0.103 | −0.021 | 0.179 | 0.590 | −0.176 | 0.58 | 2.39 (1.04) | 0.46 |
| C7 Pollution in the environment | −0.044 | 0.125 | 0.016 | −0.083 | 0.006 | 0.453 | 0.507 | 0.274 | 0.56 | 2.90 (1.13) | 0.37 |
| 8 Climatic influences (α = 0.76) | |||||||||||
| NC13 Climatic influences at work (e.g., cold, heat, dust exposure, solar radiation) | 0.082 | 0.115 | 0.066 | 0.129 | 0.182 | 0.111 | −0.008 | 0.844 | 0.80 | 3.10 (1.16) | 0.62 |
| NC14 Climatic influences outside of work (e.g., cold, heat, dust exposure, solar radiation) | 0.258 | 0.392 | 0.080 | 0.078 | −0.001 | −0.068 | −0.002 | 0.694 | 0.72 | 2.83 (1.12) | 0.62 |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
|---|---|---|---|---|---|---|---|---|
| 1. Psychological causes | 1 | 0.338 ** | 0.336 ** | 0.383 ** | 0.114 | 0.326 ** | 0.429 ** | 0.340 ** |
| 2. Causes outside of work | 1 | 0.411 ** | 0.175 ** | 0.185 ** | 0.192 ** | 0.239 ** | 0.358 ** | |
| 3. Skin cleansing and skin protection measures | 1 | 0.037 | 0.268 ** | 0.170 * | 0.274 ** | 0.219 ** | ||
| 4. Behavioural risk factors | 1 | 0.055 | 0.264 ** | 0.258 ** | 0.224 ** | |||
| 5. Causes at work | 1 | 0.035 | 0.058 | 0.195 ** | ||||
| 6. Other risk factors | 1 | 0.450 ** | 0.105 | |||||
| 7. External factors that cannot be influenced by the person | 1 | 0.214 ** | ||||||
| 8. Climatic influences | 1 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Ludewig, M.; Wilke, A.; Meyer, J.; John, S.M.; Rocholl, M. Modification and Psychometric Testing of the German-Language Revised Illness Perception Questionnaire (IPQ-R) in Occupational Dermatological Rehabilitation. Occup. Health 2026, 1, 23. https://doi.org/10.3390/occuphealth1020023
Ludewig M, Wilke A, Meyer J, John SM, Rocholl M. Modification and Psychometric Testing of the German-Language Revised Illness Perception Questionnaire (IPQ-R) in Occupational Dermatological Rehabilitation. Occupational Health. 2026; 1(2):23. https://doi.org/10.3390/occuphealth1020023
Chicago/Turabian StyleLudewig, Michaela, Annika Wilke, Julia Meyer, Swen Malte John, and Marc Rocholl. 2026. "Modification and Psychometric Testing of the German-Language Revised Illness Perception Questionnaire (IPQ-R) in Occupational Dermatological Rehabilitation" Occupational Health 1, no. 2: 23. https://doi.org/10.3390/occuphealth1020023
APA StyleLudewig, M., Wilke, A., Meyer, J., John, S. M., & Rocholl, M. (2026). Modification and Psychometric Testing of the German-Language Revised Illness Perception Questionnaire (IPQ-R) in Occupational Dermatological Rehabilitation. Occupational Health, 1(2), 23. https://doi.org/10.3390/occuphealth1020023

